Nov 14 (Reuters) -
* ALVEO TECHNOLOGIES ENTERS AGREEMENT WITH CDC TO DEVELOP A POINT OF NEED SPATIAL MULTIPLEXED TEST FOR AVIAN INFLUENZA A(H5) VIRUS IN HUMANS
* ALVEO TECHNOLOGIES- NEXT MONTH, TO BEGIN SHIPPING MOLECULAR TEST FOR ALL RELEVANT SUBTYPES OF AVIAN INFLUENZA (TYPE A, SUBTYPES H5, H7, H9) IN POULTRY
Source text: Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。